← Back to Search

W-GenZD Mobile Application Group for Depression

N/A
Waitlist Available
Led By Mary Margaret Gleason, MD
Research Sponsored by Woebot Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; end-of-treatment (4 weeks from baseline); change from baseline to end-of-treatment at 4 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new mobile app and online group therapy for teenagers with mild mood issues. The goal is to see if these tools help them feel better by managing their feelings and thoughts.

Eligible Conditions
  • Depression
  • Anxiety

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; end-of-treatment (4 weeks from baseline); change from baseline to end-of-treatment at 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; end-of-treatment (4 weeks from baseline); change from baseline to end-of-treatment at 4 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Usage Rating Profile-Intervention Revised (URP-IR), Acceptability Subscale
Usage Rating Profile-Intervention Revised (URP-IR), Feasibility Subscale
Secondary study objectives
Patient Health Questionnaire, 8 Items (PHQ-8)
Other study objectives
Working Alliance Inventory-Short Revised (WAI-SR)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: W-GenZD Mobile Application GroupExperimental Treatment1 Intervention
Participants assigned to the W-GenZD mobile application group will be asked to download and use the W-GenZD mobile application that will provide information and tools through a chatbot (a computer program designed to communicate with users). Participants will be invited to use the mobile application as often as they like during the 4-week treatment period - we will encourage 5 to 10 minutes of daily use.
Group II: CBT-Lite Teletherapy GroupActive Control1 Intervention
Participants assigned to the CBT-lite teletherapy group will be asked to attend 1-hour teletherapy group sessions over Zoom once a week for 4 weeks. In this group, a study clinician will cover topics such as building a coping tool box, accepting your feelings, challenging negative thoughts, and problem solving.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Woebot for Adolescents (W-GenZD) Mobile Application
2022
N/A
~150

Find a Location

Who is running the clinical trial?

Woebot HealthLead Sponsor
13 Previous Clinical Trials
1,803 Total Patients Enrolled
6 Trials studying Depression
545 Patients Enrolled for Depression
Woebot Labs, Inc.Lead Sponsor
6 Previous Clinical Trials
638 Total Patients Enrolled
3 Trials studying Depression
259 Patients Enrolled for Depression
Children's Hospital of The King's DaughtersOTHER
12 Previous Clinical Trials
1,838 Total Patients Enrolled
~40 spots leftby Nov 2025